|
The American Association of Clinical Endocrinologists and the American Diabetes Association Respond to a Study Finding that GLP-1-Based Therapies Increase the Risk of Pancreatitis |
March 29, 2013 |
53 |
|
|
Dexcom Announces Progress on a Pediatric Label for the G4 Platinum CGM and Development of New Remote Monitoring Product, Dexcom Share |
March 28, 2013 |
53 |
|
|
The American Diabetes Association estimates the economic burden of diabetes in 2012 to be $245 billion |
March 29, 2013 |
53 |
|
|
Novo Nordisk launches Tresiba (insulin degludec) in United Kingdom and Denmark |
March 29, 2013 |
53 |
|
|
Vivus Launches a Discount Save Now! Program for Qsymia |
March 29, 2013 |
53 |
|
|
FDA Approves Invokana, a New Therapy for Type 2 Diabetes |
March 31, 2013 |
53 |
|
|
Sanofi US Will Donate $10,000 to the Diabetes Hands Foundation when 10,000 Viewers Watch Strength in Numbers Documentary |
May 10, 2013 |
53 |
|
|
FDA Delays Novo Nordisk’s Tresiba and Asks for Additional Cardiovascular Data |
February 27, 2013 |
52 |
|
|
LifeScan’s OneTouch VerioSync Blood Glucose Meter Cleared by FDA |
February 27, 2013 |
52 |
|
|
FDA Approves Takeda’s DPP-4 inhibitors Nesina, Kazano, and Oseni |
February 27, 2013 |
52 |
|
|
Partnership for a Healthier America to Host Building a Healthier Future Summit |
February 27, 2013 |
52 |
|
|
The European Commission Approves Sanofi and Zealand Pharma’s GLP-1 Agonist Lyxumia (lixisenatide) |
February 27, 2013 |
52 |
|